← Leaderboards
Stephen J Oliver
Rockefeller University
$1,276,433
Attributed
$1,276,433
Total exposure
14
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $467.8K · FY2005–08$500K$375K$250K$125K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$1,276,433 · 14
By mechanism
K23$658,584 · 1
R21$464,750 · 1
M01$153,099 · 12
Top collaborators
No co-investigators on record.
Most similar at Rockefeller University
Same institution · by research overlap
- James G Krueger$4,444,811
- Jacqueline Friedman$56,664
- Shiro Horiuchi$566,780
- Patrick Anthony John Haslett$1,657,967
- James Krueger$0
Others in their field
Top investigators on “Thalidomide”
- Walter John Curran · Thomas Jefferson University$26,641,549
- William G Kaelin · Dana-Farber Cancer Institute$9,761,992
- Patricia M Rodier · University Of Rochester$5,610,286
- Michele Pagano · New York University School Of Medicine$5,565,349
- Keith R. McCrae · Case Western Reserve University$5,447,978
- Peter Leif Bergsagel · Weill Medical College Of Cornell Univ$5,124,352
Research focus
ThalidomideHuman SubjectSclerodermaHuman Therapy EvaluationCytokineClinical ResearchCollagenHelper T LymphocyteFibroblastsImmunopathology ChemotherapyBiopsySarcoidosisProtein BiosynthesisTissue /Cell CulturePatient Oriented ResearchProcollagenCellular ImmunityDrug Screening /EvaluationSkinImmunomodulatorsAntiinflammatory AgentsPathologic ProcessLeukocyte Activation /TransformationQuestionnaires
Grant awards (25)
CLINICAL TRIAL: T CELL IMMUNITY IN COLLAGEN BIOSYNTHESIS OF SCLERODERMA$1,489
M01 · FY2008 · RR · contact PI
ALTERED DENDRITIC CELL FUNCTION IN SARCOIDOSIS ANERGY$1,219
M01 · FY2008 · RR · contact PI
ALTERED DENDRITIC CELL FUNCTION IN SARCOIDOSIS ANERGY$18,147
M01 · FY2007 · RR · contact PI
T CELL IMMUNITY IN COLLAGEN BIOSYNTHESIS OF SCLERODERMA$13,413
M01 · FY2007 · RR · contact PI
ALTERED DENDRITIC CELL FUNCTION IN SARCOIDOSIS ANERGY$28,993
M01 · FY2006 · RR · contact PI
T CELL IMMUNITY IN COLLAGEN BIOSYNTHESIS OF SCLERODERMA$27,121
M01 · FY2006 · RR · contact PI
Altered Dendritic Cell Function in Sarcoidosis Anergy$295,750
R21 · FY2005 · HL
T Cell Immunity in Collagen Biosynthesis of Scleroderma$131,490
K23 · FY2005 · AR
T CELL IMMUNITY IN COLLAGEN BIOSYNTHESIS OF SCLERODERMA$35,809
M01 · FY2005 · RR
ALTERED DENDRITIC CELL FUNCTION IN SARCOIDOSIS ANERGY$4,774
M01 · FY2005 · RR
Altered Dendritic Cell Function in Sarcoidosis Anergy$169,000
R21 · FY2004 · HL
T Cell Immunity in Collagen Biosynthesis of Scleroderma$131,490
K23 · FY2004 · AR
T Cell Immunity in Collagen Biosynthesis of Scleroderma$13,465
M01 · FY2004 · RR
T-Cell Immunity in Collagen Biosynthesis of Scleroderma$8,669
M01 · FY2004 · RR
T Cell Immunity in Collagen Biosynthesis of Scleroderma$131,490
K23 · FY2003 · AR
T Cell Immunity in Collagen Biosynthesis of Scleroderma$131,490
K23 · FY2002 · AR
PILOT INVESTIGATION OF THE SAFETY AND EFFICACY OF THALIDOMIDE IN SCLERODERMA$0
M01 · FY2002 · RR
PILOT INVESTIGATION OF SAFETY AND EFFICACY OF THALIDOMIDE IN SARCOIDOSIS$0
M01 · FY2002 · RR
T Cell Immunity in Collagen Biosynthesis of Scleroderma$82,826
K23 · FY2001 · AR
T Cell Immunity in Collagen Biosynthesis of Scleroderma$49,798
K23 · FY2001 · AR
PILOT INVESTIGATION OF THE SAFETY AND EFFICACY OF THALIDOMIDE IN SCLERODERMA$0
M01 · FY2001 · RR
PILOT INVESTIGATION OF SAFETY AND EFFICACY OF THALIDOMIDE IN SARCOIDOSIS$0
M01 · FY2001 · RR
PILOT INVESTIGATION OF SAFETY AND EFFICACY OF THALIDOMIDE IN SARCOIDOSIS$0
M01 · FY2000 · RR
BLOOD FROM AUTOIMMUNE DISEASES WITH THALIDOMIDE THERAPY$0
M01 · FY2000 · RR
PILOT INVESTIGATION OF THE SAFETY AND EFFICACY OF THALIDOMIDE IN SCLERODERMA$0
M01 · FY2000 · RR